                         SEQUENCE LISTING

<110>  UCL Business PLC
 
<120>  Improved Lipid-Peptide Nanocomplex Formulation Liposome for mRNA 
       delivery to cells

<130>  P027350WO

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  transfection vector

<400>  1

Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


Arg Val Arg Arg Gly Ala Cys Tyr Gly Leu Pro His Lys Phe Cys Gly 
            20                  25                  30          


<210>  2
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  transfection vector


<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  epsilon amino hexanoic acid

<220>
<221>  MOD_RES
<222>  (23)..(23)
<223>  epsilon amino hexanoic acid

<400>  2

Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


Arg Val Arg Arg Xaa Ser Xaa Gly Ala Cys Tyr Gly Leu Pro His Lys 
            20                  25                  30          


Phe Cys Gly 
        35  


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker

<400>  3

Arg Val Arg Arg 
1               


<210>  4
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polycationic nucleic acid binding component

<400>  4

Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  epsilon amino hexanoic acid

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  epsilon amino hexanoic acid

<400>  5

Xaa Ser Xaa Gly Ala 
1               5   


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell surface receptor binding component

<400>  6

Cys Tyr Gly Leu Pro His Lys Phe Cys Gly 
1               5                   10  


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell surface receptor binding component

<400>  7

Tyr Gly Leu Pro His Lys Phe 
1               5           


<210>  8
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  transfection vector

<400>  8

Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


Arg Val Arg Arg Gly Ala Cys Arg Gly Asp Cys Leu Gly 
            20                  25                  


<210>  9
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  transfection vector

<400>  9

Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


Gly Ala Cys Tyr Gly Leu Pro His Lys Phe Cys Gly 
            20                  25              


